Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers

Journal of Virology

Volumn 84, Issue 18, 2010, Pages 9463-9471

  Huang, Jinghe ^a   Burke, Patrick S ^a   Cung, Thai Duong Hong ^a   Pereyra, Florencia ^a   Toth, Ildiko ^a   Walker, Bruce D ^a,b   Borges, Luis ^c   Lichterfeld, Mathias ^a   Yu, Xu G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; LEUKOCYTE ANTIGEN; LILRB1 PROTEIN, HUMAN; LILRB3 PROTEIN, HUMAN; MONOCLONAL ANTIBODY;

ADULT; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOKINE RELEASE; ELITE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 CONTROLLER; FEMALE; FLOW CYTOMETRY; GENE INACTIVATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOREGULATION; INFECTION PREVENTION; INNATE IMMUNITY; MALE; MYELOID DENDRITIC CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; VIREMIA; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; ANTIGEN PRESENTATION; COMPARATIVE STUDY; DENDRITIC CELL; GENE SILENCING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SECRETION (PROCESS); YOUNG ADULT;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, CD; CYTOKINES; DENDRITIC CELLS; FEMALE; GENE SILENCING; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; YOUNG ADULT;

EID: 77956033397     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01009-10     Document Type: Article

References (50)

1. Allan, D. S., A. J. McMichael, and V. M. Braud. 2000. The ILT family of leukocyte receptors. Immunobiology 202:34-41.
2. Almeida, M., M. Cordero, J. Almeida, and A. Orfao. 2005. Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection. AIDS 19:261-271.
3. Appay, V., and D. Sauce. 2008. Immune activation and inflammation in HIV-1 infection: causes and consequences. J. Pathol. 214:231-241.
4. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
5. Bello, G., C. A. Velasco-de-Castro, V. Bongertz, C. A. Rodrigues, C. B. Giacoia-Gripp, J. H. Pilotto, B. Grinsztejn, V. G. Veloso, and M. G. Morgado. 2009. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1. J. Med. Virol. 81:1681-1690.
6. Betts, M. R., M. C. Nason, S. M. West, S. C. De Rosa, S. A. Migueles, J. Abraham, M. M. Lederman, J. M. Benito, P. A. Goepfert, M. Connors, M. Roederer, and R. A. Koup. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781-4789.
7. Blankson, J. N. 2010. Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses? Antiviral Res. 85:295-302.
8. Blankson, J. N., J. R. Bailey, S. Thayil, H. C. Yang, K. Lassen, J. Lai, S. K. Gandhi, J. D. Siliciano, T. M. Williams, and R. F. Siliciano. 2007. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J. Virol. 81:2508-2518.
9. Brenchley, J. M., N. J. Karandikar, M. R. Betts, D. R. Ambrozak, B. J. Hill, L. E. Crotty, J. P. Casazza, J. Kuruppu, S. A. Migueles, M. Connors, M. Roederer, D. C. Douek, and R. A. Koup. 2003. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101:2711-2720.
10. Brown, D., J. Trowsdale, and R. Allen. 2004. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64:215-225. (Pubitemid 39120446)
11. Chang, C. C., R. Ciubotariu, J. S. Manavalan, J. Yuan, A. I. Colovai, F. Piazza, S. Lederman, M. Colonna, R. Cortesini, R. Dalla-Favera, and N. Suciu-Foca. 2002. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3:237-243.
12. Chehimi, J., L. Azzoni, M. Farabaugh, S. A. Creer, C. Tomescu, A. Hancock, A. Mackiewicz, L. D'Alessandro, S. Ghanekar, A. S. Foulkes, K. Mounzer, J. Kostman, and L. J. Montaner. 2007. Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment. J. Immunol. 179:2642-2650.
13. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186:1809-1818.
14. Colonna, M., J. Samaridis, M. Cella, L. Angman, R. L. Allen, C. A. O'Callaghan, R. Dunbar, G. S. Ogg, V. Cerundolo, and A. Rolink. 1998. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160:3096-3100.
15. Dillon, S. M., K. B. Robertson, S. C. Pan, S. Mawhinney, A. L. Meditz, J. M. Folkvord, E. Connick, M. D. McCarter, and C. C. Wilson. 2008. Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection. J. Acquir. Immune Defic. Syndr. 48:1-12.
16. Donaghy, H., B. Gazzard, F. Gotch, and S. Patterson. 2003. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 101:4505-4511.
17. Fellay, J., K. V. Shianna, D. Ge, S. Colombo, B. Ledergerber, M. Weale, K. Zhang, C. Gumbs, A. Castagna, A. Cossarizza, A. Cozzi-Lepri, A. De Luca, P. Easterbrook, P. Francioli, S. Mallal, J. Martinez-Picado, J. M. Miro, N. Obel, J. P. Smith, J. Wyniger, P. Descombes, S. E. Antonarakis, N. L. Letvin, A. J. McMichael, B. F. Haynes, A. Telenti, and D. B. Goldstein. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317:944-947.
18. Geijtenbeek, T. B., and S. I. Gringhuis. 2009. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9:465-479.
19. Grassi, F., A. Hosmalin, D. McIlroy, V. Calvez, P. Debre, and B. Autran. 1999. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS 13:759-766. (Pubitemid 29224577)
20. Huang, J., J. J. Goedert, E. J. Sundberg, T. D. Cung, P. S. Burke, M. P. Martin, L. Preiss, J. Lifson, M. Lichterfeld, M. Carrington, and X. G. Yu. 2009. HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. J. Exp. Med. 206:2959-2966.
21. Huang, Y., W. A. Paxton, S. M. Wolinsky, A. U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N. R. Landau, J. Phair, D. D. Ho, and R. A. Koup. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-1243.
22. Hunt, P. W. 2009. Natural control of HIV-1 replication and long-term non-progression: overlapping but distinct phenotypes. J. Infect. Dis. 200:1636-1638.
23. Hunt, P. W., J. Brenchley, E. Sinclair, J. M. McCune, M. Roland, K. Page-Shafer, P. Hsue, B. Emu, M. Krone, H. Lampiris, D. Douek, J. N. Martin, and S. G. Deeks. 2008. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197:126-133.
24. Ince, M. N., B. Harnisch, Z. Xu, S. K. Lee, C. Lange, L. Moretta, M. Lederman, and J. Lieberman. 2004. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function. Immunology 112:531-542.
25. Kavanagh, D. G., D. E. Kaufmann, S. Sunderji, N. Frahm, S. Le Gall, D. Boczkowski, E. S. Rosenberg, D. R. Stone, M. N. Johnston, B. S. Wagner, M. T. Zaman, C. Brander, E. Gilboa, B. D. Walker, and N. Bhardwaj. 2006. Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef. Blood 107:1963-1969.
26. Kelleher, P. 2008. Immune activation and viraemia: reciprocal interactions in disease pathogenesis. J. HIV Ther. 13:76-78.
27. Kuroki, K., N. Tsuchiya, M. Shiroishi, L. Rasubala, Y. Yamashita, K. Matsuta, T. Fukazawa, M. Kusaoi, Y. Murakami, M. Takiguchi, T. Juji, H. Hashimoto, D. Kohda, K. Maenaka, and K. Tokunaga. 2005. Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. Hum. Mol. Genet. 14:2469-2480.
28. Lichterfeld, M., D. G. Kavanagh, K. L. Williams, B. Moza, S. K. Mui, T. Miura, R. Sivamurthy, R. Allgaier, F. Pereyra, A. Trocha, M. Feeney, R. T. Gandhi, E. S. Rosenberg, M. Altfeld, T. M. Allen, R. Allen, B. D. Walker, E. J. Sundberg, and X. G. Yu. 2007. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J. Exp. Med. 204:2813-2824.
29. Lichterfeld, M., D. Mou, T. D. Cung, K. L. Williams, M. T. Waring, J. Huang, F. Pereyra, A. Trocha, G. J. Freeman, E. S. Rosenberg, B. D. Walker, and X. G. Yu. 2008. Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors. Blood 112:3679-3687.
30. Lu, W., L. C. Arraes, W. T. Ferreira, and J. M. Andrieu. 2004. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat. Med. 10:1359-1365.
31. Lu, W., X. Wu, Y. Lu, W. Guo, and J. M. Andrieu. 2003. Therapeutic dendritic-cell vaccine for simian AIDS. Nat. Med. 9:27-32.
32. Migueles, S. A., A. C. Laborico, W. L. Shupert, M. S. Sabbaghian, R. Rabin, C. W. Hallahan, D. Van Baarle, S. Kostense, F. Miedema, M. McLaughlin, L. Ehler, J. Metcalf, S. Liu, and M. Connors. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068.
33. Migueles, S. A., C. M. Osborne, C. Royce, A. A. Compton, R. P. Joshi, K. A. Weeks, J. E. Rood, A. M. Berkley, J. B. Sacha, N. A. Cogliano-Shutta, M. Lloyd, G. Roby, R. Kwan, M. McLaughlin, S. Stallings, C. Rehm, M. A. O'Shea, J. Mican, B. Z. Packard, A. Komoriya, S. Palmer, A. P. Wiegand, F. Maldarelli, J. M. Coffin, J. W. Mellors, C. W. Hallahan, D. A. Follman, and M. Connors. 2008. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29:1009-1021.
34. Miura, T., M. A. Brockman, C. J. Brumme, Z. L. Brumme, J. M. Carlson, F. Pereyra, A. Trocha, M. M. Addo, B. L. Block, A. C. Rothchild, B. M. Baker, T. Flynn, A. Schneidewind, B. Li, Y. E. Wang, D. Heckerman, T. M. Allen, and B. D. Walker. 2008. Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes. J. Virol. 82:8422-8430.
35. Nakajima, H., J. Samaridis, L. Angman, and M. Colonna. 1999. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. J. Immunol. 162:5-8.
36. Pereyra, F., M. M. Addo, D. E. Kaufmann, Y. Liu, T. Miura, A. Rathod, B. Baker, A. Trocha, R. Rosenberg, E. Mackey, P. Ueda, Z. Lu, D. Cohen, T. Wrin, C. J. Petropoulos, E. S. Rosenberg, and B. D. Walker. 2008. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 197:563-571.
37. Pereyra, F., S. Palmer, T. Miura, B. L. Block, A. Wiegand, A. C. Rothchild, B. Baker, R. Rosenberg, E. Cutrell, M. S. Seaman, J. M. Coffin, and B. D. Walker. 2009. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. J. Infect. Dis. 200:984-990.
38. Pfistershammer, K., A. Lawitschka, C. Klauser, J. Leitner, R. Weigl, M. H. Heemskerk, W. F. Pickl, O. Majdic, G. A. Bohmig, G. F. Fischer, H. T. Greinix, and P. Steinberger. 2009. Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients. Blood 114:2323-2332.
39. Reis e Sousa, C. 2004. Activation of dendritic cells: translating innate into adaptive immunity. Curr. Opin. Immunol. 16:21-25.
40. Saez-Cirion, A., M. Sinet, S. Y. Shin, A. Urrutia, P. Versmisse, C. Lacabaratz, F. Boufassa, V. Avettand-Fenoel, C. Rouzioux, J. F. Delfraissy, F. Barre-Sinoussi, O. Lambotte, A. Venet, and G. Pancino. 2009. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J. Immunol. 182:7828-7837.
41. Saverino, D., M. Fabbi, F. Ghiotto, A. Merlo, S. Bruno, D. Zarcone, C. Tenca, M. Tiso, G. Santoro, G. Anastasi, D. Cosman, C. E. Grossi, and E. Ciccone. 2000. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J. Immunol. 165: 3742-3755.
42. Saverino, D., F. Ghiotto, A. Merlo, S. Bruno, L. Battini, M. Occhino, M. Maffei, C. Tenca, S. Pileri, L. Baldi, M. Fabbi, A. Bachi, A. De Santanna, C. E. Grossi, and E. Ciccone. 2004. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHCrestricted lysis of human cytomegalovirus-infected cells. J. Immunol. 172: 5629-5637.
43. Scott-Algara, D., V. Arnold, C. Didier, T. Kattan, G. Pirozzi, F. Barre-Sinoussi, and G. Pancino. 2008. The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells. PLoS One 3:e1975. (Pubitemid 351984384)
44. Sedaghat, A. R., D. A. Rastegar, K. A. O'Connell, J. B. Dinoso, C. O. Wilke, and J. N. Blankson. 2009. T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors. Clin. Infect. Dis. 49:1763-1766.
45. Sloane, D. E., N. Tedla, M. Awoniyi, D. W. Macglashan, Jr., L. Borges, K. F. Austen, and J. P. Arm. 2004. Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition. Blood 104:2832-2839.
46. Smith, M. W., M. Dean, M. Carrington, C. Winkler, G. A. Huttley, D. A. Lomb, J. J. Goedert, T. R. O'Brien, L. P. Jacobson, R. Kaslow, S. Buchbinder, E. Vittinghoff, D. Vlahov, K. Hoots, M. W. Hilgartner, and S. J. O'Brien. 1997. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277:959-965.
47. Steinman, R. M., and H. Hemmi. 2006. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311:17-58.
48. Reference deleted.
49. Vitale, M., R. Castriconi, S. Parolini, D. Pende, M. L. Hsu, L. Moretta, D. Cosman, and A. Moretta. 1999. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1+ NK cell clones. Int. Immunol. 11:29-35.
50. Young, N. T., E. C. Waller, R. Patel, A. Roghanian, J. M. Austyn, and J. Trowsdale. 2008. The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells. Blood 111:3090-3096.